HELMHOLTZ ZENTRUM FUER INFEKTIONSFORSCHUNG - Germany 

Ranking results:

Past rankings:

2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2010
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Total Project Funding:900-1000
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:200-300
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:300-400
Total Number of Projects:600-700
Total Project Funding:300-400
Networking Rank (Reputation):600-700
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:500-600
Total Number of Projects:400-500
Total Project Funding:600-700
Networking Rank (Reputation):400-500
Partner Constancy:500-600
Project Leadership Index:300-400
Diversity Index:100-200
2007
Criterium:Position:
Overall Score:200-300
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Total Project Funding:200-300
Networking Rank (Reputation):400-500
Partner Constancy:> 1000
Project Leadership Index:200-300
Diversity Index:800-900

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 28
As coordinator: 3
As participant: 20
Sole participant: 5
Coordinator / Participant Ratio: 0.15*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 1.658.828 0 0 2
2017 0 1.998.750 0 1
2016 0 4.111.943 0 2
2015 3.687.685 12.038.926 0 2 2
2014 0 1.498.392 0 1
2013 368.794 51.955.013 268.794 3 7
2012 0 1.484.016 0 1
2011 0 7.498.139 0 2
2010 2.997.137 9.498.955 0 1 4
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:

Constancy:

Total number of partners: 0
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 0
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2018-04-01Identification of the cellular sites of cytomegalovirus latency that contribute to the induction of inflationary CD8 T cell memory against the virus. MISTROcoordinator159.4611
2018-02-01Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies NovAnIcoordinator1.499.3671
2017-05-01Clearance Of Microbial Biofilms by Advancing diagnostics and Therapy COMBATparticipant1.998.7501
2016-10-01Rapid Antimicrobial susceptibility testing and phylogenetic Identification RAPIDparticipant150.0001
2016-05-01Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology EDGEparticipant3.961.9439
2015-10-01European Network linking informatics and genomics of helper T cells ENLIGHT-TENcoordinator3.354.68511
2015-06-01European Marine Biological Research Infrastructure Cluster to promote the Blue Bioeconomy EMBRICparticipant9.041.61127
2015-01-01Golden Mycological Triangle – joining forces to exploit mycological biodiversity for novel anti-infectives and other beneficial metabolites GoMyTricoordinator333.0002
2015-01-01Design and development of advanced NAnomedicines to overcome Biological BArriers and to treat severe diseases NABBAparticipant2.997.3156
2014-01-01Identifying the immune and microbial network controlling the IL-22 – IL-22bp axis to open the doors for targeted therapies IL-22 AND IL-22BPparticipant1.498.3922
2013-12-01Parasite glycobiology and anti-parasitic strategies GLYCOPARparticipant3.450.85612
2013-12-01Rewiring the Streptomyces cell factory for cost-effective production of biomolecules STREPSYNTHparticipant8.691.07016
2013-10-01"Interplay of inflammasomes, commensals and pathogens at mucosal interfaces" INFLACOMMcoordinator100.0001
2013-10-01"Innovative, mechanistic-based strategies for delivery of therapeutic macromolecules across cellular and biological barriers" PATHCHOOSERparticipant3.036.6149
2013-10-01"A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines" UNIVAXparticipant5.999.45711
2013-05-01Influence of Streptococcal virulence factors on host autophagy regulation GASAUTOPHAGYcoordinator168.7941
2013-04-01Molecular mechanisms of bacterial motility and type-III secretion in virulence of Salmonella SALMOVIRcoordinator100.0001
2013-02-01Protecting the health of Europeans by improving methods for the detection of pathogens in drinking water and water used in food preparation AQUAVALENSparticipant8.963.42543
2013-01-01Improving Outcome of Necrotizing Fasciitis: Elucidation of Complex Host and Pathogen Signatures that Dictate Severity of Tissue Infection INFECTparticipant11.913.59115
2013-01-01Development of mouse mutant resources for functional analyses of human diseases - Enhancing the translation of research into innovation INFRAFRONTIER-I3participant9.900.00023
2012-01-01Exploitation of actinomycetes genomics using synthetic and system biology approaches EXPLOGENparticipant1.484.0161
2011-11-01New Technologies and Production Tools for Complex Protein Biologics ComplexINCparticipant5.999.6838
2011-04-01Molecular mechanisms of persistent antigenic stimulation in cytomegalovirus infection CMVAgSTIMULUSparticipant1.498.4561
2010-11-01European Infrastructure of Open Screening Platforms for Chemical Biology EU-OPENSCREENparticipant3.700.00023
2010-11-01Genomic predictors and oncogenic drivers in hepatocellular carcinoma HEPTROMICparticipant2.999.47810
2010-11-01Towards an individualised therapy and prevention of multi-drug resistant disease RESISTOMEparticipant1.479.4871
2010-04-01Molecular Approaches and MetaGenomic Investigations for optimizing Clean-up of PAH contaminated sites MAGICPAHcoordinator2.997.13714
2010-01-01Novel strategies for the prevention and control of persistent infections NOPERSISTparticipant1.319.99012

Alias institution names:

  • HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG